Ergoteles LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$6,539,000
+2312.9%
96,027
+1032.0%
0.23%
+2775.0%
Q2 2022$271,0000.0%8,483
-8.4%
0.01%
-27.3%
Q4 2021$271,000
-92.7%
9,263
-89.9%
0.01%
-90.5%
Q1 2021$3,727,000
+29.7%
91,449
+75.4%
0.12%
-69.5%
Q3 2020$2,874,00052,1260.38%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2020
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 460,000$14,872,00013.19%
VHCP Management II, LLC 141,611$4,578,0003.76%
Perceptive Advisors 1,186,630$38,363,0002.84%
RTW INVESTMENTS, LP 175,156$5,663,0001.87%
Casdin Capital, LLC 65,000$2,101,0001.86%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,163,811$37,626,0001.52%
RA Capital Management 457,142$14,779,0001.46%
VHCP Management, LLC 60,691$1,962,0001.19%
Iguana Healthcare Management, LLC 110,000$3,556,0001.17%
Partner Investment Management, L.P. 15,634$505,0000.83%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders